Valentijn A Schweitzer

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Extracorporeal Membrane Oxygenation

Respiratory Tract

Staphylococcus Aureus

Top Venues

Therapeutic drug monitoring

PLoS computational biology

Expert review of anti-infective therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas G van Gelder, Valentijn A Schweitzer, Esther V Uijtendaal, Maaike A Sikma
Catching the Culprit: Benzylpenicillin Neurotoxicity Confirmed by Therapeutic Drug Monitoring in a Critically Ill Patient With Continuous Venovenous Hemofiltration. Therapeutic drug monitoring 46 (4) (2024)
Thomas G van Gelder, Valentijn A Schweitzer, Esther V Uijtendaal, Maaike A Sikma
Catching the Culprit: Benzylpenicillin Neurotoxicity Confirmed by Therapeutic Drug Monitoring in a Critically Ill Patient with Continuous Venovenous Hemofiltration. Therapeutic drug monitoring (2024)
Thomas G van Gelder, Valentijn A Schweitzer, Esther V Uijtendaal, Maaike A Sikma
Catching the Culprit: Benzylpenicillin Neurotoxicity Confirmed by Therapeutic Drug Monitoring in a Critically Ill Patient with Continuous Venovenous Hemofiltration. Therapeutic drug monitoring (2024)
Noortje G Godijk, Martin C J Bootsma, Cornelis H Van Werkhoven, Valentijn A Schweitzer, Sabine C de Greeff, Annelot F Schoffelen, Marc J M Bonten
Does plasmid-based beta-lactam resistance increase E. coli infections: Modelling addition and replacement mechanisms. PLoS computational biology 18 (3) (2022)
Inger Van Heijl, Valentijn A Schweitzer, Paul D van der Linden, Marc J M Bonten, Cornelis H Van Werkhoven
Impact of antimicrobial de-escalation on mortality: a literature review of study methodology and recommendations for observational studies. Expert review of anti-infective therapy 18 (5) (2020)
Inger Van Heijl, Valentijn A Schweitzer, Lufang Zhang, Paul D van der Linden, Cornelis H Van Werkhoven, Douwe F Postma
Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions. Drugs & aging 35 (5) (2018)